U.S. markets closed
  • S&P 500

    3,934.83
    +18.45 (+0.47%)
     
  • Dow 30

    31,458.40
    +27.70 (+0.09%)
     
  • Nasdaq

    14,095.47
    +69.70 (+0.50%)
     
  • Russell 2000

    2,289.36
    +4.04 (+0.18%)
     
  • Crude Oil

    59.73
    +1.49 (+2.56%)
     
  • Gold

    1,824.80
    -2.00 (-0.11%)
     
  • Silver

    27.45
    +0.40 (+1.49%)
     
  • EUR/USD

    1.2130
    -0.0006 (-0.05%)
     
  • 10-Yr Bond

    1.2000
    +0.0420 (+3.63%)
     
  • GBP/USD

    1.3845
    +0.0027 (+0.20%)
     
  • USD/JPY

    104.9050
    +0.1550 (+0.15%)
     
  • BTC-USD

    47,378.02
    -466.30 (-0.97%)
     
  • CMC Crypto 200

    980.79
    +24.08 (+2.52%)
     
  • FTSE 100

    6,589.79
    +61.07 (+0.94%)
     
  • Nikkei 225

    29,520.07
    -42.86 (-0.14%)
     

iRhythm Investor Alert: Shareholder Class Action Lawsuit Filed

  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
  • Oops!
    Something went wrong.
    Please try again later.

BOSTON, MA / ACCESSWIRE / February 12, 2021 / The Thornton Law Firm announces that a class action lawsuit has been filed on behalf of investors of iRhythm Technologies, Inc. (NASDAQ:IRTC). The case is currently in the lead plaintiff stage. Investors ... Thornton Law Firm LLP

BOSTON, MA / ACCESSWIRE / February 12, 2021 / The Thornton Law Firm announces that a class action lawsuit has been filed on behalf of investors of iRhythm Technologies, Inc. (NASDAQ:IRTC). The case is currently in the lead plaintiff stage. Investors who purchased IRTC stock or other securities between August 4, 2020 and January 28, 2021 may contact the Thornton Law Firm's investor protection team by visiting www.tenlaw.com/cases/iRhythm to submit their information. Investors may also email investors@tenlaw.com or call 617-531-3917.

FOR MORE INFORMATION: www.tenlaw.com/cases/iRhythm

The complaint alleges that iRhythm and its senior executive made misleading statements to investors and failed to disclose that: (1) iRhythm's business would suffer as a result of the CMS's rulemaking; (2) reimbursement rates would in fact plummet; and (3) a lack of national pricing in the CMS rule and fee schedule would cause uncertainty and weakness in iRhythm's business.

Interested iRhythm investors have until April 2, 2021 to retain counsel and apply to be a lead plaintiff if they are interested to do so. Investors do not need to be a lead plaintiff in order to be a class member. A lead plaintiff acts on behalf of all other investor class members in managing the class action. If investors choose to take no action, they can remain an absent class member. The class has not yet been certified. Until certification occurs, investors are not represented by an attorney.

FOR MORE INFORMATION: www.tenlaw.com/cases/iRhythm

Thornton Law Firm's securities attorneys are highly experienced in representing investors in recovering damages caused by violations of the securities laws. Its attorneys have established track records litigating securities cases in courts throughout the country and recovering losses on behalf of investors. This may be considered Attorney Advertising in some jurisdictions. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

CONTACT:

Thornton Law Firm LLP
1 Lincoln Street
State Street Financial Center
Boston, MA 02111
www.tenlaw.com/cases/iRhythm

SOURCE: Thornton Law Firm LLP



View source version on accesswire.com:
https://www.accesswire.com/629538/iRhythm-Investor-Alert-Shareholder-Class-Action-Lawsuit-Filed